Edition:
India

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

6.19USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$6.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
212,928
52-wk High
$6.69
52-wk Low
$3.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 3.98 -0.261
FY 2017 Dec '17 3.89 -0.198
Sep '17 8.76 -0.181
Jun '17 3.10 -0.210
Mar '17 9.44 -0.189
FY 2016 Dec '16 8.98 -0.061
Sep '16 7.76 -0.156
Jun '16 4.79 -0.221
Mar '16 4.82 -0.310
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 7 4.62 7.43 0.00 0.00
Quarter Ending Dec-18 7 5.39 8.38 0.00 0.00
Year Ending Dec-18 8 17.46 24.70 4.00 21.38
Year Ending Dec-19 7 19.83 37.08 0.10 24.03
Earnings (per share)
Quarter Ending Sep-18 7 -0.24 -0.19 -0.31 -0.21
Quarter Ending Dec-18 7 -0.23 -0.15 -0.34 -0.25
Year Ending Dec-18 8 -0.96 -0.79 -1.20 -0.75
Year Ending Dec-19 7 -0.94 -0.77 -1.26 -0.82
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -45.39 14.99 6.05
EPS (TTM) % -26.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for BioCryst Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -10.60 -13.68 16 --
13 Week -8.57 -13.02 36 --
26 Week -27.96 -33.44 23 --
52 Week 17.53 -0.39 63 --
YTD -17.38 -27.44 29 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 94.64%
# of Holders: 149
Total Shares Held: 93,423,183
3 Mo. Net Change: 3,477,650
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 9
# Reduced Positions: 3
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.